NCT07071571 (IONM) is a NA clinical trial of neuromonitoring in Thryoid Cancer, sponsored by SB Istanbul Education and Research Hospital.

Who is sponsoring NCT07071571?

NCT07071571 is sponsored by SB Istanbul Education and Research Hospital.

What drugs are being tested in NCT07071571?

Interventions in NCT07071571: neuromonitoring.

What condition does NCT07071571 study?

NCT07071571 studies Thryoid Cancer, parathyrıoid Adenoma.

Is NCT07071571 still recruiting?

NCT07071571 is currently not yet recruiting. Last updated 17 July 2025.

Last reviewed 2025-07-17 · How we verify

NCT07071571: IONM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

New Intraoperative Nerve Monitoring Device

Not yet recruiting NA Last updated 17 July 2025

What this trial tests

NA trial testing neuromonitoring in Thryoid Cancer in 40 participants. Not yet recruiting.

Timeline

1 August 2025

Primary endpoint
1 January 2026

1 December 2026

Quick facts

Lead sponsor	SB Istanbul Education and Research Hospital
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	1 August 2025
Primary completion	1 January 2026
Estimated completion	1 December 2026

Drugs / interventions tested

neuromonitoring

Conditions studied

Thryoid Cancer — all drugs for Thryoid Cancer →
parathyrıoid Adenoma — all drugs for parathyrıoid Adenoma →

Sponsor

SB Istanbul Education and Research Hospital

Who can join

Adults 18 to 70, any sex, with Thryoid Cancer or parathyrıoid Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is testing a new device developed to protect the recurrent laryngeal nerve, which is at risk of damage during thyroid and parathyroid surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other SB Istanbul Education and Research Hospital trials

Trials by the same sponsor.

NCT06873087 — Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema · Phase 4 · completed
NCT03780998 — Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases · unknown
NCT04940169 — Anterior Cruciate Ligament Reconstruction Made With Hamstring Tendon And Quadriceps Tendon Autografts · NA · completed
NCT03051308 — University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation · NA · unknown
NCT04230343 — Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07071571 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by SB Istanbul Education and Research Hospital
Last refreshed: 17 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07071571.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing